Arlington Scientific

Executive Summary

Arlington Scientific is a privately held medical technology company founded in 1995 and headquartered in Springville, Utah. The company specializes in the development and manufacture of in-vitro diagnostic test kits, non-mammalian blocking buffers, and specialized diagnostic instruments, including the ASI Evolution Automated RPR Syphilis Analyzer and nasal curettes for rapid viral testing. Additionally, it provides blood donor lounges, catering to the blood banking sector. With a focus on infectious disease diagnostics and blood screening, Arlington Scientific serves a global market, leveraging its expertise in syphilis testing and rapid viral diagnostics. The company’s product portfolio addresses critical needs in clinical laboratories and blood donation centers, positioning it as a niche player in the broader diagnostics industry. Looking ahead, Arlington Scientific is poised to benefit from increasing demand for rapid and accurate diagnostic solutions, particularly in the areas of syphilis and viral testing. The company’s established manufacturing capabilities and regulatory experience provide a foundation for potential product line expansions and geographic market penetration. While operating in a competitive landscape, Arlington Scientific’s specialized offerings and long-standing industry presence support a stable growth outlook. Key opportunities include the upgrade cycle for its ASI Evolution Analyzer, expansion of its rapid viral testing product line, and deeper penetration into blood donor screening markets.

Upcoming Catalysts (preview)

• Q3 2026Next-generation ASI Evolution Analyzer launch70% success
• Q4 2026FDA clearance for expanded rapid viral test panel60% success
• Q2 2026Major partnership for blood donor lounge installations80% success